For Practitioners
MSIcare helps oncologists & pathologists predict patient response to cancer therapies.
MSI Detection: The Missing Link In Personalized Oncology
What is Microsatellite Instability?
MSI is a hallmark of dMMR cancers, affecting immunotherapy response.
Why It Matters
MSI testing is now recommended across multiple cancer types (NCCN, ESMO).
MSIcare in Clinical Practice
Generate MSI reports directly from patient samples in routine practice.
Simple Steps To MSI Testing
1
🧬 Upload patient tumor genomic data (NGS) to our MSIcare platform.
2
🔬 MSIcare analyzes for microsatellite instability markers.
3
📄 Receive a report with the MSI score (percentage of MSI present).
4
🩺 Guide personalized treatment with confidence.
Contact Us
Paris, France
Address
34 Rue Crozatier – 75012 PARIS
Lyon, France
